pharmaphorum
NOVEMBER 25, 2020
Jefferies expects that the company expects sales of $14 billion could be at risk by 2027 from patent expiries of Tasigna, Promacta, Jakavi, Gilenya and Entresto. Uptake of biosimilars in the US has been better than hoped, perhaps aided by hospitals focusing on cost because COVID-19 has curtailed income from surgery.
STAT
JULY 24, 2023
The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in 2027.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 21, 2023
A few hospitals in Denmark already have small-scale facilities for manufacturing products for these innovative treatments. The Novo Nordisk Foundation Cellerator is expected to be in operation in 2027. CGT manufacturing QC market to value $2.8b
STAT
JULY 25, 2023
The House Ways & Means Committee proposed a package that includes a new provision to ensure Medicare patients pay for medicines they pick up at pharmacies based on discounted prices insurers negotiate with drugmakers, instead of higher list prices, starting in 2027 , STAT reports.
The deprescribing.org Blog
JUNE 2, 2023
falls, fractures, cognition problems, and hospitalizations). In Ontario, more than half of LTC residents with diabetes are treated too strictly (i.e. A1c < 7%). This puts residents at risk for harms like low blood sugar and its consequences (e.g.,
The Happy PharmD
SEPTEMBER 4, 2024
Did you know that the infusion pharmacy market is projected to reach $20 billion dollars by 2027? This flexibility extends to career transitions, allowing pharmacists to move between hospital settings, ambulatory care, and community pharmacy without extensive retraining.
Pharmaceutical Technology
OCTOBER 13, 2022
According to AorticLab, 190,000 patients worldwide underwent TAVI procedures in 2020 and, with an ageing population, it predicts that by 2027 there could be 390,000 cases. This is an important benefit for the hospital. The TAVI procedure carries an inherent risk of stroke and of these, 50% are disabling.
Expert insights. Personalized for you.
119 
Let's personalize your content